Not just insulin: early increases in glucagon in type 2 diabetes are linked to fatty liver disease: Study Dr. Kamal Kant Kohli16 May 2026 9:00 AM ISTUntil now, research into type 2 diabetes has focused primarily on insulin: if the body's cells become less responsive to the hormone produced in the...
Adding Metformin with GLP-1RA: What are the Five Points Clinicians Need to Know?- Dr NK Singh Dr N K Singh14 May 2026 10:59 AM ISTIndia's metabolic burden is rising; T2DM prevalence, BMI, and cholesterol are all worsening. With the loss of injectable semaglutide exclusivity in...
Medical Bulletin 09/May/2026 Anshika Mishra9 May 2026 3:00 PM ISTHere are the top medical news for today:New Study Highlights Cranberry Juice Benefits Against Antibiotic-Resistant UTIs A glass of cranberry juice...
High salivery nitritre Levels Linked to Better Glycemic Control in T2DM: Study Dr Kartikeya Kohli9 May 2026 9:45 AM ISTResearchers have found in a new research that elevated salivery nitritre levels were associated with improved glycemic control, enhanced insulin...
Kyoto University Researchers Identify Key Regulator Controlling Insulin Production in the Body Anshika Mishra9 May 2026 8:15 AM ISTHidden deep inside the pancreas, a tiny stress-response protein may hold the key to protecting insulin-producing cells from collapse in Type 2...
Metformin: Anchor in the Metabolic Journey of Prediabetes Care- Dr Dwaipayan Deb Dr Dwaipayan Deb29 April 2026 11:24 AM ISTPrediabetes affects 634.8 million adults globally, i.e., approximately 12% of the adult population (IDF, 2025), with 30.4% prevalence among Indian...
Intraperitoneal Therapy Superior to multiple insulin injections in Early Diabetic Nephropathy: Study Dr. Shravani Dali24 April 2026 9:15 PM ISTResearchers have found in a new study that Intraperitoneal (IP) therapy demonstrated better efficacy than MSII in improving both renal function and...
Metformin in Weight Loss Maintenance: A Possible Opportunity Post-GLP-RA Discontinuation?- Dr. Ashok Kumar Das Dr. Ashok Kumar Das21 April 2026 12:14 PM ISTPatients who achieved weight loss with GLP-1 Receptor Agonists (RAs) can sustain their results with generic anti-obesity medications, including...
Dapagliflozin and Sitagliptin FDC in Indian T2D: 5 Points Clinicians May Like to Know - Dr K Baraneedharan Dr. K. Baraneedharan9 April 2026 12:00 PM ISTThe burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective intervention is essential to...
Metformin: Anchoring Potential in GLP-1 RA Care Journey Dr Manjunath Havalappa Dodamani8 April 2026 12:59 PM ISTIndia is confronting a metabolic health crisis of significant magnitude, 254 million adults with generalised obesity, 351 million with abdominal...
Insulin pills may soon replace daily injections: Study Dr. Kamal Kant Kohli27 March 2026 10:00 AM ISTFor more than 100 years, scientists have pursued the idea of insulin in pill form, often described as a "dream" treatment for diabetes. The challenge...
Tegoprubart Shows Promise for Insulin Independence After Islet Transplant: Study Dr. Kamal Kant Kohli19 March 2026 10:00 AM ISTNew trial data indicates that Tegoprubart, a CD40L-selective humanized monoclonal antibody, may help protect transplanted islet cells while avoiding...
